These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25789346)

  • 21. The art of managing human immunodeficiency virus infection: a balancing act.
    Reiss P
    Clin Infect Dis; 2009 Nov; 49(10):1602-4. PubMed ID: 19842978
    [No Abstract]   [Full Text] [Related]  

  • 22. Sexually transmitted infection with an immune-escape mutant hepatitis B virus in an hepatitis B virus-vaccinated individual with acute HIV-hepatitis C virus infection.
    Ingiliz P; Krznaric I; Obermeier M
    AIDS; 2013 Feb; 27(4):667-8. PubMed ID: 23364445
    [No Abstract]   [Full Text] [Related]  

  • 23. Extensive nodular secondary syphilis with prozone phenomenon.
    Battistella M; Le Cleach L; Lacert A; Perrin P
    Arch Dermatol; 2008 Aug; 144(8):1078-9. PubMed ID: 18711100
    [No Abstract]   [Full Text] [Related]  

  • 24. [Primary and secondary syphilis in a pregnant woman].
    Badri T; Cherif F; Sioud Dhrif A; Ben Tekaya N; Ben Osman Dhahri A
    Tunis Med; 2008 Jun; 86(6):606-8. PubMed ID: 19222140
    [No Abstract]   [Full Text] [Related]  

  • 25. Efavirenz + emtricitabine + tenofovir: new combination. HIV infection: do not modify ongoing therapy just to use one less tablet. Better adherence than with separate dosing has not been demonstrated, while reduced efficacy is plausible.
    Prescrire Int; 2009 Jun; 18(101):105. PubMed ID: 19637416
    [No Abstract]   [Full Text] [Related]  

  • 26. A once-daily combination tablet (Atripla) for HIV.
    Med Lett Drugs Ther; 2006 Sep; 48(1244):78-9. PubMed ID: 17001298
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.
    Elzi L; Marzolini C; Furrer H; Ledergerber B; Cavassini M; Hirschel B; Vernazza P; Bernasconi E; Weber R; Battegay M;
    Arch Intern Med; 2010 Jan; 170(1):57-65. PubMed ID: 20065200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Collaboration begins on combined drug.
    AIDS Patient Care STDS; 2005 Feb; 19(2):129. PubMed ID: 15747431
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immune reconstitution inflammatory syndrome associated with eosinophilic pustular folliculitis in an HIV-infected patient].
    Springinsfeld G; Roth B; Martinot M; Tortel MC; Batard ML
    Med Mal Infect; 2011 Jan; 41(1):49-50. PubMed ID: 21050684
    [No Abstract]   [Full Text] [Related]  

  • 30. Quiz Page January 2015: acute kidney injury in a patient with well-controlled HIV infection.
    Lum EL; Huang S; Huang J; Lassman C
    Am J Kidney Dis; 2015 Jan; 65(1):A22-5. PubMed ID: 25523807
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial.
    Landman R; Koulla-Shiro S; Sow PS; Ngolle M; Diallo MB; Guèye NF; Le Moing V; Eymard-Duvernay S; Benalycherif A; Charpentier C; Peytavin G; Delaporte E; Girard PM;
    Antivir Ther; 2014; 19(1):51-9. PubMed ID: 23970206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First of a kind in HIV treatment.
    FDA Consum; 2006; 40(6):34. PubMed ID: 17333565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human immunodeficiency virus-positive secondary syphilis mimicking cutaneous T-cell lymphoma.
    Yamashita M; Fujii Y; Ozaki K; Urano Y; Iwasa M; Nakamura S; Fujii S; Abe M; Sato Y; Yoshino T
    Diagn Pathol; 2015 Oct; 10():185. PubMed ID: 26449225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug interactions. Super pills-the treatments of the future?
    TreatmentUpdate; 2006; 18(3):2-3. PubMed ID: 17209236
    [No Abstract]   [Full Text] [Related]  

  • 35. Preexposure prophylaxis reduces HIV risk in injection-drug users.
    Rosenberg K
    Am J Nurs; 2013 Sep; 113(9):17. PubMed ID: 23985594
    [No Abstract]   [Full Text] [Related]  

  • 36. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1.
    ; Arrivé E; Chaix ML; Nerrienet E; Blanche S; Rouzioux C; Coffie PA; Kruy Leang S; McIntyre J; Avit D; Srey VH; Gray G; N'Dri-Yoman T; Diallo A; Ekouévi DK; Dabis F
    AIDS; 2009 Apr; 23(7):825-33. PubMed ID: 19307941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single nodular lesion on the scalp: a quiz. Diagnosis: nodular secondary syphilis.
    Jang YH; Sim JH; Kim YC; Lee ES
    Acta Derm Venereol; 2011 Jun; 91(4):491-4. PubMed ID: 21369679
    [No Abstract]   [Full Text] [Related]  

  • 38. FDA notifications. Generic efavirenz/emtricitabine/fenofovir has tentative approval.
    AIDS Alert; 2009 Oct; 24(10):119-20. PubMed ID: 20034141
    [No Abstract]   [Full Text] [Related]  

  • 39. Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial.
    Barrios A; Negredo E; Domingo P; Estrada V; Labarga P; Asensi V; Morales D; Santos J; Clotet B; Soriano V;
    Antivir Ther; 2005; 10(7):825-32. PubMed ID: 16312178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scaly pruritic plaques in an HIV-positive patient.
    Wanat KA; Rutnin S; Kovarik CL
    Arch Dermatol; 2012 Nov; 148(11):1317-8. PubMed ID: 23165841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.